Inhibiting wear particles-induced osteolysis with doxycycline

Acta Pharmacologica Sinica

Volumn 28, Issue 10, 2007, Pages 1603-1610

  Zhang, Chao ^a,b   Tang, Ting Ting ^a   Ren, Wei Ping ^c   Zhang, Xiao Ling ^b   Dai, Ke Rong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aseptic loosening; Doxycycline; Osteolysis; Wear particles

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; DOXYCYCLINE; HEMATOXYLIN; OSTEOCLAST DIFFERENTIATION FACTOR; POLY(METHYL METHACRYLATE); TOLONIUM CHLORIDE; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE;

ANIMAL CELL; ANIMAL TISSUE; ARTHROPLASTY; ARTICLE; BONE MARROW CELL; BONE TISSUE; C57BL 6 MOUSE; CALVARIA; CELL COUNT; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; MONOCYTE; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; RABBIT;

ACID PHOSPHATASE; ANIMALS; ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; BONE RESORPTION; CELL SURVIVAL; DOXYCYCLINE; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOGENESIS; OSTEOLYSIS; PARTICLE SIZE; POLYETHYLENES; POLYMETHYL METHACRYLATE; RABBITS;

EID: 34848873077     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00638.x     Document Type: Article

References (28)

1. Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop 2001 393 : 66 70.
2. Bauer TW. Particles and periimplant bone resorption. Clin Orthop 2002 405 : 138 43.
3. Baumann B, Rader CP, Seufert J, Noth U, Rolf O, Eulert J, et al. Effects of polyethylene and TiA1V wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthop 2004 75 : 295 302.
4. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 2006 54 : 3221 32.
5. Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, et al. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 2002 23 : 517 26.
6. Yang SY, Wu B, Mayton L, Mukherjee P, Robbins PD, Evans CH, et al. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 2004 115 : 483 91.
7. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT. Osteolysis: basic science. Clin Orthop 2001 393 : 71 7.
8. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Min Res 2001 16 : 338 47.
9. Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL, et al. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 2005 23 : 501 10.
10. Rawal SY, Rawal YB. Non-antimicrobial properties of tetracy-clines-dental and medical implications. West Indian Med J 2001 50 : 105 8.
11. Bettany JT, Peet NM, Wolowacz RG, Skerry TM, Grabowski PS. Tetracyclines induce apoptosis in osteoclasts. Bone 2000 27 : 75 80.
12. Holmes SG, Still K, Buttle DJ, Bishop NJ, Grabowski PS. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone 2004 35 : 471 8.
13. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001 83 : 1789 97.
14. Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000 18 : 849 55.
15. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998 95 : 3597 602.
16. Sobue T, Hakeda Y, Kobayashi Y, Hayakawa H, Yamashita K, Aoki T, et al. Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J Bone Miner Res 2001 16 : 2205 14.
17. Ragab AA, Van De Motter R, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999 17 : 803 9.
18. Munger P, Roder C, Ackermann-Liebrich U, Busato A. Patient-related risk factors leading to aseptic stem loosening in total hip arthroplasty: a case-control study of 5,035 patients. Acta Orthop 2006 77 : 567 74.
19. Wright TM, Goodman SB. Implant wear in total joint replacement: clinical and biologic issues, material and design considerations. American Academy of Orthopaedic Surgeons 2001 http://www4.aaos.org/product/productpage.cfm?code= 02522).
20. Porter ML. The long-term results of Charnley low-friction arthroplasty in young patients who have congenital dislocation, degenerative osteoarthrosis, or rheumatoid arthritis. J Bone Joint Surg Am. 1997 79-Am : 1599 617.
21. von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Brankamp J, et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 2005 75 : 288 94.
22. Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. Viral interleukin-10 gene inhibition of inflammation, osteoclasto-genesis, and bone resorption in response to titanium particles. Arthritis Rheum 2002 46 : 1298 308.
23. Iwase M, Kim KJ, Kobayashi Y, Itoh M, Itoh T. A novel bisphos-phonate inhibits inflammatory bone resorption in a rat osteoly-sis model with continuous infusion of polyethylene particles. J Orthop Res 2002 20 : 499 505.
24. Wise LM, Waldman SD, Kasra M, Cheung R, Binnington A, Kandel RA, et al. Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog. Calcif Tissue Int 2005 77 : 367 75.
25. von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Henschke F, et al. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 2005 26 : 3549 55.
26. Schwarz EM, Campbell D, Totterman S, Boyd A, O'Keefe RJ, Looney RJ. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs placebo. J Orthop Res 2003 21 : 1049 55.
27. Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Chen HS. The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. J Bone Joint Surg Am 2003 85-Am : 2121 6.
28. Talmo CT, Shanbhag A, Rubash HE. Nonsurgical management of osteolysis: challenges and opportunities. Clin Orthop 2006 453 : 254 64.